IIM
ORKA

INTECH Investment Management’s Oruka Therapeutics ORKA Stock Holding History

INTECH Investment Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$572K Sell
11,660
-3,153
-21% -$110K 0.01% 1275
2025
Q4 		$449K Buy
14,813
+2,307
+18% +$64.3K ﹤0.01% 1564
2025
Q3 		$240K Sell
12,506
-2,519
-17% -$37.3K ﹤0.01% 1952
2025
Q2 		$168K Buy
+15,025
New +$157K ﹤0.01% 2147

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

INTECH Investment Management's ORKA Position: Q1 2026 in Review

INTECH Investment Management reduced its Oruka Therapeutics (ORKA) stake by 21% in Q1 2026, selling an estimated $110K and leaving 11,660 shares worth $572K. The position accounts for 0.01% of the portfolio, ranked #1275.

INTECH Investment Management first reported a position in ORKA in Q2 2025 and has held it in 4 quarters since. 184 funds tracked by Wall St. Rank hold ORKA as of Q1 2026.

  • INTECH Investment Management held 11,660 shares of Oruka Therapeutics worth $572K as of Q1 2026.
  • INTECH Investment Management sold 3,153 Oruka Therapeutics shares in Q1 2026, an estimated $110K.
  • Oruka Therapeutics made up 0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1275 holding.
  • INTECH Investment Management first reported a position in Oruka Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • 184 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.